These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment. Tenser RB; Polman CH Neurology; 2009 Mar; 72(13):1191-2; author reply 1192. PubMed ID: 19332703 [No Abstract] [Full Text] [Related]
14. When do the federal regulations allow placebo-controlled trials in children? Miller FG; Wendler D; Wilfond B J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527 [No Abstract] [Full Text] [Related]
15. World Medical Association clarifies rules on placebo controlled trials. Ferriman A BMJ; 2001 Oct; 323(7317):825. PubMed ID: 11597960 [No Abstract] [Full Text] [Related]
16. More on the use of placebo controls. IRB; 2001; 23(6):11. PubMed ID: 12737177 [No Abstract] [Full Text] [Related]
17. Brazil. Tough placebo rules leave scientists out in the cold. Vieira CL Science; 2002 Jan; 295(5553):264. PubMed ID: 11786626 [No Abstract] [Full Text] [Related]
18. Active-controlled versus placebo-controlled trials. Friedman JH Med Health R I; 1999 Jun; 82(6):186. PubMed ID: 10402831 [No Abstract] [Full Text] [Related]
19. Scientific and ethical issues in the use of placebo and active controls in clinical trials. Ellenberg SS J Bone Miner Res; 2003 Jun; 18(6):1121-4. PubMed ID: 12817767 [No Abstract] [Full Text] [Related]
20. Distinguishing dilemmas in the ethics of placebo-controlled trials. Kovach K Am J Bioeth; 2002; 2(2):32-3. PubMed ID: 12189072 [No Abstract] [Full Text] [Related] [Next] [New Search]